HEADER ISOMERASE/IMMUNOSUPPRESSANT 26-OCT-05 2ESL TITLE HUMAN CYCLOPHILIN C IN COMPLEX WITH CYCLOSPORIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE C; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: RESIDUES 24-212; COMPND 5 SYNONYM: PPIASE C,CYCLOPHILIN C,ROTAMASE C; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CYCLOSPORIN A; COMPND 10 CHAIN: I, J, K, L, M, N; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPIC, CYPC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28-LIC; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: TOLYPOCLADIUM INFLATUM; SOURCE 14 ORGANISM_TAXID: 29910 KEYWDS ISOMERASE-IMMUNOSUPPRESSANT COMPLEX, CYCLOPHILIN-CYCLOSPORIN COMPLEX, KEYWDS 2 CYCLOSPORIN A, IMMUNOSUPRESSANT, CYCLOPHILIN, SGC, STRUCTURAL KEYWDS 3 GENOMICS, STRUCTURAL GENOMICS CONSORTIUM EXPDTA X-RAY DIFFRACTION AUTHOR J.R.WALKER,T.DAVIS,E.M.NEWMAN,P.J.FINERTY JR.,F.MACKENZIE,J.WEIGELT, AUTHOR 2 M.SUNDSTROM,C.ARROWSMITH,A.EDWARDS,A.BOCHKAREV,S.DHE-PAGANON, AUTHOR 3 STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 8 07-FEB-18 2ESL 1 JRNL REVDAT 7 21-JUN-17 2ESL 1 DBREF SEQADV REVDAT 6 27-JUL-11 2ESL 1 REMARK REVDAT 5 13-JUL-11 2ESL 1 VERSN REVDAT 4 24-FEB-09 2ESL 1 VERSN REVDAT 3 10-OCT-06 2ESL 1 AUTHOR REVDAT DBREF SEQADV REVDAT 2 24-JAN-06 2ESL 1 JRNL REVDAT 1 13-DEC-05 2ESL 0 JRNL AUTH T.L.DAVIS,J.R.WALKER,V.CAMPAGNA-SLATER,P.J.FINERTY, JRNL AUTH 2 R.PARAMANATHAN,G.BERNSTEIN,F.MACKENZIE,W.TEMPEL,H.OUYANG, JRNL AUTH 3 W.H.LEE,E.Z.EISENMESSER,S.DHE-PAGANON JRNL TITL STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF THE HUMAN JRNL TITL 2 CYCLOPHILIN FAMILY OF PEPTIDYL-PROLYL ISOMERASES. JRNL REF PLOS BIOL. V. 8 00439 2010 JRNL REFN ESSN 1545-7885 JRNL PMID 20676357 JRNL DOI 10.1371/JOURNAL.PBIO.1000439 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 90042 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4733 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6515 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.61 REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 332 REMARK 3 BIN FREE R VALUE : 0.3050 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8826 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 798 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.07000 REMARK 3 B22 (A**2) : -1.46000 REMARK 3 B33 (A**2) : 2.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.150 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.143 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.099 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.007 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9048 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12258 ; 1.373 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1104 ; 6.265 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 348 ;33.363 ;24.138 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1416 ;13.992 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;19.054 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1386 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6774 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 4316 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 6233 ; 0.321 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 770 ; 0.133 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): 14 ; 0.338 ; 0.200 REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 35 ; 0.197 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 25 ; 0.163 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): 1 ; 0.164 ; 0.200 REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5802 ; 1.726 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 9180 ; 2.597 ; 4.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3654 ; 3.349 ; 5.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3078 ; 4.920 ; 7.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2ESL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000035041. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-3 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 95283 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 36.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 25.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.51500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.680 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.84 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG550 MME, 10MM ZINC ACETATE, REMARK 280 100MM MES, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.10150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.62500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.90100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.62500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.10150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.90100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8550 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 17950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -320.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, I, J, K, L, REMARK 350 AND CHAINS: M, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -136.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, I, J, K REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 9 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -143.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F, L, M, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 10 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D, J, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 11 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E, I, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 12 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, F, K, N REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. REMARK 400 HERE, CYCLOSPORIN A IS REPRESENTED BY THE SEQUENCE (SEQRES) REMARK 400 REMARK 400 THE CYCLOSPORIN A IS CYCLIC PEPTIDE, A MEMBER OF IMMUNOSUPPRESSANT REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: CYCLOSPORIN A REMARK 400 CHAIN: I, J, K, L, M, N REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION REMARK 400 IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 23 REMARK 465 SER A 24 REMARK 465 GLY A 25 REMARK 465 ALA A 26 REMARK 465 GLU A 27 REMARK 465 GLY A 28 REMARK 465 PHE A 29 REMARK 465 ARG A 30 REMARK 465 LYS A 31 REMARK 465 GLY B 23 REMARK 465 SER B 24 REMARK 465 GLY B 25 REMARK 465 ALA B 26 REMARK 465 GLU B 27 REMARK 465 GLY B 28 REMARK 465 PHE B 29 REMARK 465 ARG B 30 REMARK 465 LYS B 31 REMARK 465 GLY C 23 REMARK 465 SER C 24 REMARK 465 GLY C 25 REMARK 465 ALA C 26 REMARK 465 GLU C 27 REMARK 465 GLY C 28 REMARK 465 PHE C 29 REMARK 465 ARG C 30 REMARK 465 LYS C 31 REMARK 465 GLY D 23 REMARK 465 SER D 24 REMARK 465 GLY D 25 REMARK 465 ALA D 26 REMARK 465 GLU D 27 REMARK 465 GLY D 28 REMARK 465 PHE D 29 REMARK 465 ARG D 30 REMARK 465 LYS D 31 REMARK 465 GLY E 23 REMARK 465 SER E 24 REMARK 465 GLY E 25 REMARK 465 ALA E 26 REMARK 465 GLU E 27 REMARK 465 GLY E 28 REMARK 465 PHE E 29 REMARK 465 ARG E 30 REMARK 465 LYS E 31 REMARK 465 GLY F 23 REMARK 465 SER F 24 REMARK 465 GLY F 25 REMARK 465 ALA F 26 REMARK 465 GLU F 27 REMARK 465 GLY F 28 REMARK 465 PHE F 29 REMARK 465 ARG F 30 REMARK 465 LYS F 31 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O3 SO4 B 7 O HOH B 2002 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 93 19.15 58.32 REMARK 500 PHE A 94 -75.04 -128.32 REMARK 500 THR A 102 -85.13 -114.69 REMARK 500 PHE A 163 -8.18 -140.62 REMARK 500 PHE B 94 -69.43 -127.07 REMARK 500 THR B 102 -86.41 -108.74 REMARK 500 PHE B 163 -6.17 -141.65 REMARK 500 PHE C 94 -75.17 -127.78 REMARK 500 THR C 102 -94.29 -98.62 REMARK 500 PHE C 163 -3.28 -143.33 REMARK 500 ASP C 211 55.71 -145.84 REMARK 500 ASP D 93 17.74 59.24 REMARK 500 PHE D 94 -75.51 -125.63 REMARK 500 THR D 102 -80.32 -104.84 REMARK 500 PHE D 163 -7.28 -146.66 REMARK 500 PHE E 94 -71.20 -128.28 REMARK 500 THR E 102 -94.07 -106.92 REMARK 500 THR E 151 -166.77 -160.11 REMARK 500 PHE E 163 -2.43 -141.80 REMARK 500 PHE F 94 -68.36 -131.81 REMARK 500 THR F 102 -91.79 -112.27 REMARK 500 PHE F 163 -7.64 -144.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2039 DISTANCE = 5.89 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 1 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 93 OD2 REMARK 620 2 ASP C 93 OD1 93.8 REMARK 620 3 ASP C 93 OD2 103.4 48.4 REMARK 620 4 ASP B 93 OD1 147.7 117.3 92.1 REMARK 620 5 ASP B 93 OD2 99.9 150.4 102.6 48.5 REMARK 620 6 ASP A 93 OD1 47.8 115.4 149.7 117.4 93.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 4 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 174 NE2 REMARK 620 2 HIS B 174 NE2 114.6 REMARK 620 3 HIS C 174 NE2 111.6 112.8 REMARK 620 4 HOH A2001 O 107.5 103.6 106.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA D 2 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP D 93 OD2 REMARK 620 2 ASP F 93 OD1 95.5 REMARK 620 3 ASP E 93 OD2 100.4 149.3 REMARK 620 4 ASP E 93 OD1 147.9 115.7 48.7 REMARK 620 5 ASP D 93 OD1 48.3 114.7 95.4 117.1 REMARK 620 6 ASP F 93 OD2 99.6 49.2 102.0 95.9 146.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 5 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 174 NE2 REMARK 620 2 HIS E 174 NE2 115.8 REMARK 620 3 HIS F 174 NE2 110.1 109.2 REMARK 620 4 HOH D2001 O 105.6 105.6 110.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA F 3 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU F 77 OE2 REMARK 620 2 GLU F 68 OE2 142.0 REMARK 620 3 GLU E 115 OE2 108.9 108.9 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA D 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA F 3 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 5 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 8 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 D 9 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 E 10 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 F 11 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN J OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN K OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN L OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN M OF CYCLOSPORIN A REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN N OF CYCLOSPORIN A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 C REMARK 900 RELATED ID: 1C5F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CYCLOPHILIN-LIKE DOMAIN FROM BRUGIA MALAYI REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CSA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF E.COLI CYCLOPHILIN (F112W) COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 1CWA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 1CWB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 1CWC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 D REMARK 900 RELATED ID: 1CWH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A MODIFIED AT POSITION 7 REMARK 900 RELATED ID: 1CWI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITION 7 REMARK 900 RELATED ID: 1CWJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN D AT POSITIONS 5 AND 7. REMARK 900 RELATED ID: 1CWL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 8 REMARK 900 RELATED ID: 1CWO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH NODIFIED REMARK 900 CYCLOSPORIN C AT POSITIONS 1, AND 9 REMARK 900 RELATED ID: 1CYA RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYB RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN CYCLOPHILIN COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1CYN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN B COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 1 REMARK 900 RELATED ID: 1M63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CALCINEURIN-CYCLOPHILIN-CYCLOSPORIN COMPLEX REMARK 900 RELATED ID: 1MF8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CALCINEURIN COMPLEXED WITH HUMAN REMARK 900 CYCLOPHILIN AND CYCLOSPORIN A REMARK 900 RELATED ID: 1MIK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 6 REMARK 900 RELATED ID: 1QNG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN COMPLEXED REMARK 900 WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1QNH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM CYCLOPHILIN (DOUBLE REMARK 900 MUTANT) COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 1XQ7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYCLOPHILIN COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2OJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN J COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2POY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CRYPTOSPORIDIUM PARVUM IOWA II CYCLOPHILIN A REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2RMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH CYCLOSPORIN REMARK 900 A REMARK 900 RELATED ID: 2RMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN A COMPLEXED WITH MODIFIED REMARK 900 CYCLOSPORIN A AT POSITION 5 REMARK 900 RELATED ID: 2RMC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE CYCLOPHILIN C COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 2WFJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PPIASE DOMAIN OF HUMAN CYCLOPHILIN G REMARK 900 COMPLEXED WITH CYCLOSPORIN A REMARK 900 RELATED ID: 2X2C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ACETYL-CYPA COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2X7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF PPIL1 COMPLEXED WITH CYCLOSPORINE A REMARK 900 RELATED ID: 2Z6W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLOPHILIN D IN COMPLEX WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3BO7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOSPHILIN A FROM TOXOPLASMA GONDII REMARK 900 COMPLEXED WIT CYCLOSPORIN A REMARK 900 RELATED ID: 3CYS RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE HUMAN CYCLOSPORIN A COMPLEXED WITH REMARK 900 CYCLOSPORIN A REMARK 900 RELATED ID: 3EOV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CYCLOPHILIN FROM LEISHMANIA DONOVANI COMPLEXED REMARK 900 WITH CYCLOSPORIN A DBREF 2ESL A 24 212 UNP P45877 PPIC_HUMAN 24 212 DBREF 2ESL B 24 212 UNP P45877 PPIC_HUMAN 24 212 DBREF 2ESL C 24 212 UNP P45877 PPIC_HUMAN 24 212 DBREF 2ESL D 24 212 UNP P45877 PPIC_HUMAN 24 212 DBREF 2ESL E 24 212 UNP P45877 PPIC_HUMAN 24 212 DBREF 2ESL F 24 212 UNP P45877 PPIC_HUMAN 24 212 DBREF 2ESL I 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2ESL J 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2ESL K 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2ESL L 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2ESL M 1 11 NOR NOR00033 NOR00033 1 11 DBREF 2ESL N 1 11 NOR NOR00033 NOR00033 1 11 SEQADV 2ESL GLY A 23 UNP P45877 EXPRESSION TAG SEQADV 2ESL GLY B 23 UNP P45877 EXPRESSION TAG SEQADV 2ESL GLY C 23 UNP P45877 EXPRESSION TAG SEQADV 2ESL GLY D 23 UNP P45877 EXPRESSION TAG SEQADV 2ESL GLY E 23 UNP P45877 EXPRESSION TAG SEQADV 2ESL GLY F 23 UNP P45877 EXPRESSION TAG SEQRES 1 A 190 GLY SER GLY ALA GLU GLY PHE ARG LYS ARG GLY PRO SER SEQRES 2 A 190 VAL THR ALA LYS VAL PHE PHE ASP VAL ARG ILE GLY ASP SEQRES 3 A 190 LYS ASP VAL GLY ARG ILE VAL ILE GLY LEU PHE GLY LYS SEQRES 4 A 190 VAL VAL PRO LYS THR VAL GLU ASN PHE VAL ALA LEU ALA SEQRES 5 A 190 THR GLY GLU LYS GLY TYR GLY TYR LYS GLY SER LYS PHE SEQRES 6 A 190 HIS ARG VAL ILE LYS ASP PHE MET ILE GLN GLY GLY ASP SEQRES 7 A 190 ILE THR THR GLY ASP GLY THR GLY GLY VAL SER ILE TYR SEQRES 8 A 190 GLY GLU THR PHE PRO ASP GLU ASN PHE LYS LEU LYS HIS SEQRES 9 A 190 TYR GLY ILE GLY TRP VAL SER MET ALA ASN ALA GLY PRO SEQRES 10 A 190 ASP THR ASN GLY SER GLN PHE PHE ILE THR LEU THR LYS SEQRES 11 A 190 PRO THR TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY LYS SEQRES 12 A 190 VAL ILE ASP GLY MET THR VAL VAL HIS SER ILE GLU LEU SEQRES 13 A 190 GLN ALA THR ASP GLY HIS ASP ARG PRO LEU THR ASN CYS SEQRES 14 A 190 SER ILE ILE ASN SER GLY LYS ILE ASP VAL LYS THR PRO SEQRES 15 A 190 PHE VAL VAL GLU ILE ALA ASP TRP SEQRES 1 B 190 GLY SER GLY ALA GLU GLY PHE ARG LYS ARG GLY PRO SER SEQRES 2 B 190 VAL THR ALA LYS VAL PHE PHE ASP VAL ARG ILE GLY ASP SEQRES 3 B 190 LYS ASP VAL GLY ARG ILE VAL ILE GLY LEU PHE GLY LYS SEQRES 4 B 190 VAL VAL PRO LYS THR VAL GLU ASN PHE VAL ALA LEU ALA SEQRES 5 B 190 THR GLY GLU LYS GLY TYR GLY TYR LYS GLY SER LYS PHE SEQRES 6 B 190 HIS ARG VAL ILE LYS ASP PHE MET ILE GLN GLY GLY ASP SEQRES 7 B 190 ILE THR THR GLY ASP GLY THR GLY GLY VAL SER ILE TYR SEQRES 8 B 190 GLY GLU THR PHE PRO ASP GLU ASN PHE LYS LEU LYS HIS SEQRES 9 B 190 TYR GLY ILE GLY TRP VAL SER MET ALA ASN ALA GLY PRO SEQRES 10 B 190 ASP THR ASN GLY SER GLN PHE PHE ILE THR LEU THR LYS SEQRES 11 B 190 PRO THR TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY LYS SEQRES 12 B 190 VAL ILE ASP GLY MET THR VAL VAL HIS SER ILE GLU LEU SEQRES 13 B 190 GLN ALA THR ASP GLY HIS ASP ARG PRO LEU THR ASN CYS SEQRES 14 B 190 SER ILE ILE ASN SER GLY LYS ILE ASP VAL LYS THR PRO SEQRES 15 B 190 PHE VAL VAL GLU ILE ALA ASP TRP SEQRES 1 C 190 GLY SER GLY ALA GLU GLY PHE ARG LYS ARG GLY PRO SER SEQRES 2 C 190 VAL THR ALA LYS VAL PHE PHE ASP VAL ARG ILE GLY ASP SEQRES 3 C 190 LYS ASP VAL GLY ARG ILE VAL ILE GLY LEU PHE GLY LYS SEQRES 4 C 190 VAL VAL PRO LYS THR VAL GLU ASN PHE VAL ALA LEU ALA SEQRES 5 C 190 THR GLY GLU LYS GLY TYR GLY TYR LYS GLY SER LYS PHE SEQRES 6 C 190 HIS ARG VAL ILE LYS ASP PHE MET ILE GLN GLY GLY ASP SEQRES 7 C 190 ILE THR THR GLY ASP GLY THR GLY GLY VAL SER ILE TYR SEQRES 8 C 190 GLY GLU THR PHE PRO ASP GLU ASN PHE LYS LEU LYS HIS SEQRES 9 C 190 TYR GLY ILE GLY TRP VAL SER MET ALA ASN ALA GLY PRO SEQRES 10 C 190 ASP THR ASN GLY SER GLN PHE PHE ILE THR LEU THR LYS SEQRES 11 C 190 PRO THR TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY LYS SEQRES 12 C 190 VAL ILE ASP GLY MET THR VAL VAL HIS SER ILE GLU LEU SEQRES 13 C 190 GLN ALA THR ASP GLY HIS ASP ARG PRO LEU THR ASN CYS SEQRES 14 C 190 SER ILE ILE ASN SER GLY LYS ILE ASP VAL LYS THR PRO SEQRES 15 C 190 PHE VAL VAL GLU ILE ALA ASP TRP SEQRES 1 D 190 GLY SER GLY ALA GLU GLY PHE ARG LYS ARG GLY PRO SER SEQRES 2 D 190 VAL THR ALA LYS VAL PHE PHE ASP VAL ARG ILE GLY ASP SEQRES 3 D 190 LYS ASP VAL GLY ARG ILE VAL ILE GLY LEU PHE GLY LYS SEQRES 4 D 190 VAL VAL PRO LYS THR VAL GLU ASN PHE VAL ALA LEU ALA SEQRES 5 D 190 THR GLY GLU LYS GLY TYR GLY TYR LYS GLY SER LYS PHE SEQRES 6 D 190 HIS ARG VAL ILE LYS ASP PHE MET ILE GLN GLY GLY ASP SEQRES 7 D 190 ILE THR THR GLY ASP GLY THR GLY GLY VAL SER ILE TYR SEQRES 8 D 190 GLY GLU THR PHE PRO ASP GLU ASN PHE LYS LEU LYS HIS SEQRES 9 D 190 TYR GLY ILE GLY TRP VAL SER MET ALA ASN ALA GLY PRO SEQRES 10 D 190 ASP THR ASN GLY SER GLN PHE PHE ILE THR LEU THR LYS SEQRES 11 D 190 PRO THR TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY LYS SEQRES 12 D 190 VAL ILE ASP GLY MET THR VAL VAL HIS SER ILE GLU LEU SEQRES 13 D 190 GLN ALA THR ASP GLY HIS ASP ARG PRO LEU THR ASN CYS SEQRES 14 D 190 SER ILE ILE ASN SER GLY LYS ILE ASP VAL LYS THR PRO SEQRES 15 D 190 PHE VAL VAL GLU ILE ALA ASP TRP SEQRES 1 E 190 GLY SER GLY ALA GLU GLY PHE ARG LYS ARG GLY PRO SER SEQRES 2 E 190 VAL THR ALA LYS VAL PHE PHE ASP VAL ARG ILE GLY ASP SEQRES 3 E 190 LYS ASP VAL GLY ARG ILE VAL ILE GLY LEU PHE GLY LYS SEQRES 4 E 190 VAL VAL PRO LYS THR VAL GLU ASN PHE VAL ALA LEU ALA SEQRES 5 E 190 THR GLY GLU LYS GLY TYR GLY TYR LYS GLY SER LYS PHE SEQRES 6 E 190 HIS ARG VAL ILE LYS ASP PHE MET ILE GLN GLY GLY ASP SEQRES 7 E 190 ILE THR THR GLY ASP GLY THR GLY GLY VAL SER ILE TYR SEQRES 8 E 190 GLY GLU THR PHE PRO ASP GLU ASN PHE LYS LEU LYS HIS SEQRES 9 E 190 TYR GLY ILE GLY TRP VAL SER MET ALA ASN ALA GLY PRO SEQRES 10 E 190 ASP THR ASN GLY SER GLN PHE PHE ILE THR LEU THR LYS SEQRES 11 E 190 PRO THR TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY LYS SEQRES 12 E 190 VAL ILE ASP GLY MET THR VAL VAL HIS SER ILE GLU LEU SEQRES 13 E 190 GLN ALA THR ASP GLY HIS ASP ARG PRO LEU THR ASN CYS SEQRES 14 E 190 SER ILE ILE ASN SER GLY LYS ILE ASP VAL LYS THR PRO SEQRES 15 E 190 PHE VAL VAL GLU ILE ALA ASP TRP SEQRES 1 F 190 GLY SER GLY ALA GLU GLY PHE ARG LYS ARG GLY PRO SER SEQRES 2 F 190 VAL THR ALA LYS VAL PHE PHE ASP VAL ARG ILE GLY ASP SEQRES 3 F 190 LYS ASP VAL GLY ARG ILE VAL ILE GLY LEU PHE GLY LYS SEQRES 4 F 190 VAL VAL PRO LYS THR VAL GLU ASN PHE VAL ALA LEU ALA SEQRES 5 F 190 THR GLY GLU LYS GLY TYR GLY TYR LYS GLY SER LYS PHE SEQRES 6 F 190 HIS ARG VAL ILE LYS ASP PHE MET ILE GLN GLY GLY ASP SEQRES 7 F 190 ILE THR THR GLY ASP GLY THR GLY GLY VAL SER ILE TYR SEQRES 8 F 190 GLY GLU THR PHE PRO ASP GLU ASN PHE LYS LEU LYS HIS SEQRES 9 F 190 TYR GLY ILE GLY TRP VAL SER MET ALA ASN ALA GLY PRO SEQRES 10 F 190 ASP THR ASN GLY SER GLN PHE PHE ILE THR LEU THR LYS SEQRES 11 F 190 PRO THR TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY LYS SEQRES 12 F 190 VAL ILE ASP GLY MET THR VAL VAL HIS SER ILE GLU LEU SEQRES 13 F 190 GLN ALA THR ASP GLY HIS ASP ARG PRO LEU THR ASN CYS SEQRES 14 F 190 SER ILE ILE ASN SER GLY LYS ILE ASP VAL LYS THR PRO SEQRES 15 F 190 PHE VAL VAL GLU ILE ALA ASP TRP SEQRES 1 I 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 J 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 K 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 L 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 M 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA SEQRES 1 N 11 DAL MLE MLE MVA BMT ABA SAR MLE VAL MLE ALA HET DAL I 1 5 HET MLE I 2 9 HET MLE I 3 9 HET MVA I 4 8 HET BMT I 5 13 HET ABA I 6 6 HET SAR I 7 5 HET MLE I 8 9 HET MLE I 10 9 HET DAL J 1 5 HET MLE J 2 9 HET MLE J 3 9 HET MVA J 4 8 HET BMT J 5 13 HET ABA J 6 6 HET SAR J 7 5 HET MLE J 8 9 HET MLE J 10 9 HET DAL K 1 5 HET MLE K 2 9 HET MLE K 3 9 HET MVA K 4 8 HET BMT K 5 13 HET ABA K 6 6 HET SAR K 7 5 HET MLE K 8 9 HET MLE K 10 9 HET DAL L 1 5 HET MLE L 2 9 HET MLE L 3 9 HET MVA L 4 8 HET BMT L 5 13 HET ABA L 6 6 HET SAR L 7 5 HET MLE L 8 9 HET MLE L 10 9 HET DAL M 1 5 HET MLE M 2 9 HET MLE M 3 9 HET MVA M 4 8 HET BMT M 5 13 HET ABA M 6 6 HET SAR M 7 5 HET MLE M 8 9 HET MLE M 10 9 HET DAL N 1 5 HET MLE N 2 9 HET MLE N 3 9 HET MVA N 4 8 HET BMT N 5 13 HET ABA N 6 6 HET SAR N 7 5 HET MLE N 8 9 HET MLE N 10 9 HET CA A 1 1 HET ZN A 4 1 HET SO4 A 6 5 HET SO4 B 7 5 HET SO4 C 8 5 HET CA D 2 1 HET ZN D 5 1 HET SO4 D 9 5 HET SO4 E 10 5 HET CA F 3 1 HET SO4 F 11 5 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE HETNAM CA CALCIUM ION HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION FORMUL 7 DAL 6(C3 H7 N O2) FORMUL 7 MLE 24(C7 H15 N O2) FORMUL 7 MVA 6(C6 H13 N O2) FORMUL 7 BMT 6(C10 H19 N O3) FORMUL 7 ABA 6(C4 H9 N O2) FORMUL 7 SAR 6(C3 H7 N O2) FORMUL 13 CA 3(CA 2+) FORMUL 14 ZN 2(ZN 2+) FORMUL 15 SO4 6(O4 S 2-) FORMUL 24 HOH *798(H2 O) HELIX 1 1 VAL A 63 GLY A 76 1 14 HELIX 2 2 PRO A 153 ASP A 157 5 5 HELIX 3 3 GLY A 169 LEU A 178 1 10 HELIX 4 4 VAL B 63 GLY B 76 1 14 HELIX 5 5 PRO B 153 ASP B 157 5 5 HELIX 6 6 GLY B 169 LEU B 178 1 10 HELIX 7 7 VAL C 63 GLY C 76 1 14 HELIX 8 8 PRO C 153 ASP C 157 5 5 HELIX 9 9 GLY C 169 LEU C 178 1 10 HELIX 10 10 VAL D 63 GLY D 76 1 14 HELIX 11 11 PRO D 153 ASP D 157 5 5 HELIX 12 12 GLY D 169 LEU D 178 1 10 HELIX 13 13 VAL E 63 GLY E 76 1 14 HELIX 14 14 PRO E 153 ASP E 157 5 5 HELIX 15 15 GLY E 169 LEU E 178 1 10 HELIX 16 16 VAL F 63 GLY F 76 1 14 HELIX 17 17 PRO F 153 ASP F 157 5 5 HELIX 18 18 GLY F 169 LEU F 178 1 10 SHEET 1 AA 8 ARG A 89 ILE A 91 0 SHEET 2 AA 8 MET A 95 GLY A 98 -1 O MET A 95 N ILE A 91 SHEET 3 AA 8 PHE A 146 THR A 149 -1 O PHE A 146 N GLY A 98 SHEET 4 AA 8 TRP A 131 MET A 134 -1 O TRP A 131 N THR A 149 SHEET 5 AA 8 VAL A 162 ASP A 168 -1 N PHE A 163 O VAL A 132 SHEET 6 AA 8 LYS A 49 LEU A 58 -1 O VAL A 55 N ILE A 167 SHEET 7 AA 8 SER A 35 ILE A 46 -1 N THR A 37 O LEU A 58 SHEET 8 AA 8 CYS A 191 VAL A 206 -1 O SER A 192 N ARG A 45 SHEET 1 BA 2 SER B 35 VAL B 36 0 SHEET 2 BA 2 PHE B 205 VAL B 206 -1 O PHE B 205 N VAL B 36 SHEET 1 BB 8 PHE B 87 ILE B 91 0 SHEET 2 BB 8 MET B 95 GLY B 98 -1 O MET B 95 N ILE B 91 SHEET 3 BB 8 PHE B 146 THR B 149 -1 O PHE B 146 N GLY B 98 SHEET 4 BB 8 TRP B 131 MET B 134 -1 O TRP B 131 N THR B 149 SHEET 5 BB 8 VAL B 162 ASP B 168 -1 N PHE B 163 O VAL B 132 SHEET 6 BB 8 LYS B 49 LEU B 58 -1 O VAL B 55 N ILE B 167 SHEET 7 BB 8 LYS B 39 ILE B 46 -1 O VAL B 40 N ILE B 56 SHEET 8 BB 8 CYS B 191 ILE B 199 -1 O SER B 192 N ARG B 45 SHEET 1 CA 2 SER C 35 VAL C 36 0 SHEET 2 CA 2 PHE C 205 VAL C 206 -1 O PHE C 205 N VAL C 36 SHEET 1 CB 8 ARG C 89 ILE C 91 0 SHEET 2 CB 8 MET C 95 GLY C 98 -1 O MET C 95 N ILE C 91 SHEET 3 CB 8 PHE C 146 THR C 149 -1 O PHE C 146 N GLY C 98 SHEET 4 CB 8 TRP C 131 MET C 134 -1 O TRP C 131 N THR C 149 SHEET 5 CB 8 VAL C 162 ASP C 168 -1 N PHE C 163 O VAL C 132 SHEET 6 CB 8 LYS C 49 LEU C 58 -1 O VAL C 55 N ILE C 167 SHEET 7 CB 8 LYS C 39 ILE C 46 -1 O VAL C 40 N ILE C 56 SHEET 8 CB 8 CYS C 191 ILE C 199 -1 O SER C 192 N ARG C 45 SHEET 1 DA 2 SER D 35 VAL D 36 0 SHEET 2 DA 2 PHE D 205 VAL D 206 -1 O PHE D 205 N VAL D 36 SHEET 1 DB 8 PHE D 87 ILE D 91 0 SHEET 2 DB 8 MET D 95 GLY D 98 -1 O MET D 95 N ILE D 91 SHEET 3 DB 8 PHE D 146 THR D 149 -1 O PHE D 146 N GLY D 98 SHEET 4 DB 8 TRP D 131 MET D 134 -1 O TRP D 131 N THR D 149 SHEET 5 DB 8 VAL D 162 ASP D 168 -1 N PHE D 163 O VAL D 132 SHEET 6 DB 8 LYS D 49 LEU D 58 -1 O VAL D 55 N ILE D 167 SHEET 7 DB 8 LYS D 39 ILE D 46 -1 O VAL D 40 N ILE D 56 SHEET 8 DB 8 CYS D 191 ILE D 199 -1 O SER D 192 N ARG D 45 SHEET 1 EA 8 PHE E 87 ILE E 91 0 SHEET 2 EA 8 MET E 95 GLY E 98 -1 O MET E 95 N ILE E 91 SHEET 3 EA 8 PHE E 146 THR E 149 -1 O PHE E 146 N GLY E 98 SHEET 4 EA 8 TRP E 131 MET E 134 -1 O TRP E 131 N THR E 149 SHEET 5 EA 8 VAL E 162 ASP E 168 -1 N PHE E 163 O VAL E 132 SHEET 6 EA 8 LYS E 49 LEU E 58 -1 O VAL E 55 N ILE E 167 SHEET 7 EA 8 SER E 35 ILE E 46 -1 N THR E 37 O LEU E 58 SHEET 8 EA 8 CYS E 191 VAL E 206 -1 O SER E 192 N ARG E 45 SHEET 1 FA 2 SER F 35 VAL F 36 0 SHEET 2 FA 2 PHE F 205 VAL F 206 -1 O PHE F 205 N VAL F 36 SHEET 1 FB 8 PHE F 87 ILE F 91 0 SHEET 2 FB 8 MET F 95 GLY F 98 -1 O MET F 95 N ILE F 91 SHEET 3 FB 8 PHE F 146 THR F 149 -1 O PHE F 146 N GLY F 98 SHEET 4 FB 8 TRP F 131 MET F 134 -1 O TRP F 131 N THR F 149 SHEET 5 FB 8 VAL F 162 ASP F 168 -1 N PHE F 163 O VAL F 132 SHEET 6 FB 8 LYS F 49 LEU F 58 -1 O VAL F 55 N ILE F 167 SHEET 7 FB 8 LYS F 39 ILE F 46 -1 O VAL F 40 N ILE F 56 SHEET 8 FB 8 CYS F 191 ILE F 199 -1 O SER F 192 N ARG F 45 LINK CA CA A 1 OD2 ASP A 93 1555 1555 1.90 LINK CA CA A 1 OD1 ASP C 93 1555 1555 2.90 LINK CA CA A 1 OD2 ASP C 93 1555 1555 1.86 LINK CA CA A 1 OD1 ASP B 93 1555 1555 2.89 LINK CA CA A 1 OD2 ASP B 93 1555 1555 2.08 LINK CA CA A 1 OD1 ASP A 93 1555 1555 2.97 LINK ZN ZN A 4 NE2 HIS A 174 1555 1555 1.98 LINK ZN ZN A 4 NE2 HIS B 174 1555 1555 2.01 LINK ZN ZN A 4 NE2 HIS C 174 1555 1555 1.96 LINK ZN ZN A 4 O HOH A2001 1555 1555 2.06 LINK CA CA D 2 OD2 ASP D 93 1555 1555 1.87 LINK CA CA D 2 OD1 ASP F 93 1555 1555 2.86 LINK CA CA D 2 OD2 ASP E 93 1555 1555 1.97 LINK CA CA D 2 OD1 ASP E 93 1555 1555 2.91 LINK CA CA D 2 OD1 ASP D 93 1555 1555 2.91 LINK CA CA D 2 OD2 ASP F 93 1555 1555 1.95 LINK ZN ZN D 5 NE2 HIS D 174 1555 1555 2.03 LINK ZN ZN D 5 NE2 HIS E 174 1555 1555 2.01 LINK ZN ZN D 5 NE2 HIS F 174 1555 1555 1.99 LINK ZN ZN D 5 O HOH D2001 1555 1555 2.17 LINK CA CA F 3 OE2 GLU F 77 1555 1555 2.28 LINK CA CA F 3 OE2 GLU F 68 1555 1555 2.06 LINK CA CA F 3 OE2 GLU E 115 1555 1455 2.26 LINK N DAL I 1 C ALA I 11 1555 1555 1.32 LINK C DAL I 1 N MLE I 2 1555 1555 1.35 LINK C MLE I 2 N MLE I 3 1555 1555 1.34 LINK C MLE I 3 N MVA I 4 1555 1555 1.35 LINK C MVA I 4 N BMT I 5 1555 1555 1.34 LINK C BMT I 5 N ABA I 6 1555 1555 1.33 LINK C ABA I 6 N SAR I 7 1555 1555 1.33 LINK C SAR I 7 N MLE I 8 1555 1555 1.34 LINK C MLE I 8 N VAL I 9 1555 1555 1.33 LINK C VAL I 9 N MLE I 10 1555 1555 1.34 LINK C MLE I 10 N ALA I 11 1555 1555 1.34 LINK C DAL J 1 N MLE J 2 1555 1555 1.34 LINK N DAL J 1 C ALA J 11 1555 1555 1.33 LINK C MLE J 2 N MLE J 3 1555 1555 1.33 LINK C MLE J 3 N MVA J 4 1555 1555 1.33 LINK C MVA J 4 N BMT J 5 1555 1555 1.36 LINK C BMT J 5 N ABA J 6 1555 1555 1.34 LINK C ABA J 6 N SAR J 7 1555 1555 1.33 LINK C SAR J 7 N MLE J 8 1555 1555 1.33 LINK C MLE J 8 N VAL J 9 1555 1555 1.33 LINK C VAL J 9 N MLE J 10 1555 1555 1.33 LINK C MLE J 10 N ALA J 11 1555 1555 1.33 LINK N DAL K 1 C ALA K 11 1555 1555 1.34 LINK C DAL K 1 N MLE K 2 1555 1555 1.34 LINK C MLE K 2 N MLE K 3 1555 1555 1.34 LINK C MLE K 3 N MVA K 4 1555 1555 1.34 LINK C MVA K 4 N BMT K 5 1555 1555 1.34 LINK C BMT K 5 N ABA K 6 1555 1555 1.34 LINK C ABA K 6 N SAR K 7 1555 1555 1.34 LINK C SAR K 7 N MLE K 8 1555 1555 1.33 LINK C MLE K 8 N VAL K 9 1555 1555 1.33 LINK C VAL K 9 N MLE K 10 1555 1555 1.33 LINK C MLE K 10 N ALA K 11 1555 1555 1.33 LINK N DAL L 1 C ALA L 11 1555 1555 1.32 LINK C DAL L 1 N MLE L 2 1555 1555 1.34 LINK C MLE L 2 N MLE L 3 1555 1555 1.34 LINK C MLE L 3 N MVA L 4 1555 1555 1.34 LINK C MVA L 4 N BMT L 5 1555 1555 1.34 LINK C BMT L 5 N ABA L 6 1555 1555 1.32 LINK C ABA L 6 N SAR L 7 1555 1555 1.33 LINK C SAR L 7 N MLE L 8 1555 1555 1.34 LINK C MLE L 8 N VAL L 9 1555 1555 1.32 LINK C VAL L 9 N MLE L 10 1555 1555 1.34 LINK C MLE L 10 N ALA L 11 1555 1555 1.34 LINK C DAL M 1 N MLE M 2 1555 1555 1.35 LINK N DAL M 1 C ALA M 11 1555 1555 1.33 LINK C MLE M 2 N MLE M 3 1555 1555 1.34 LINK C MLE M 3 N MVA M 4 1555 1555 1.34 LINK C MVA M 4 N BMT M 5 1555 1555 1.36 LINK C BMT M 5 N ABA M 6 1555 1555 1.33 LINK C ABA M 6 N SAR M 7 1555 1555 1.33 LINK C SAR M 7 N MLE M 8 1555 1555 1.33 LINK C MLE M 8 N VAL M 9 1555 1555 1.34 LINK C VAL M 9 N MLE M 10 1555 1555 1.34 LINK C MLE M 10 N ALA M 11 1555 1555 1.33 LINK C DAL N 1 N MLE N 2 1555 1555 1.34 LINK N DAL N 1 C ALA N 11 1555 1555 1.33 LINK C MLE N 2 N MLE N 3 1555 1555 1.34 LINK C MLE N 3 N MVA N 4 1555 1555 1.34 LINK C MVA N 4 N BMT N 5 1555 1555 1.36 LINK C BMT N 5 N ABA N 6 1555 1555 1.33 LINK C ABA N 6 N SAR N 7 1555 1555 1.33 LINK C SAR N 7 N MLE N 8 1555 1555 1.33 LINK C MLE N 8 N VAL N 9 1555 1555 1.33 LINK C VAL N 9 N MLE N 10 1555 1555 1.34 LINK C MLE N 10 N ALA N 11 1555 1555 1.33 SITE 1 AC1 3 ASP A 93 ASP B 93 ASP C 93 SITE 1 AC2 3 ASP D 93 ASP E 93 ASP F 93 SITE 1 AC3 3 GLU E 115 GLU F 68 GLU F 77 SITE 1 AC4 4 HIS A 174 HOH A2001 HIS B 174 HIS C 174 SITE 1 AC5 4 HIS D 174 HOH D2001 HIS E 174 HIS F 174 SITE 1 AC6 8 ASP A 168 GLY A 169 MET A 170 HOH A2002 SITE 2 AC6 8 HOH A2003 HOH A2004 GLN B 179 ALA B 180 SITE 1 AC7 8 ASP B 168 GLY B 169 MET B 170 HOH B2001 SITE 2 AC7 8 HOH B2002 HOH B2003 GLN C 179 ALA C 180 SITE 1 AC8 8 GLN A 179 ALA A 180 HOH A2126 ASP C 168 SITE 2 AC8 8 GLY C 169 MET C 170 HOH C2001 HOH C2002 SITE 1 AC9 7 ASP D 168 GLY D 169 MET D 170 HOH D2002 SITE 2 AC9 7 HOH D2003 GLN E 179 ALA E 180 SITE 1 BC1 8 ASP E 168 GLY E 169 MET E 170 HOH E2001 SITE 2 BC1 8 HOH E2002 GLN F 179 ALA F 180 HOH F2069 SITE 1 BC2 7 GLN D 179 ALA D 180 HOH D2124 ASP F 168 SITE 2 BC2 7 GLY F 169 MET F 170 HOH F2001 SITE 1 BC3 25 ARG A 89 PHE A 94 GLN A 97 GLY A 106 SITE 2 BC3 25 THR A 107 ALA A 135 ASN A 136 ALA A 137 SITE 3 BC3 25 GLN A 145 PHE A 147 TRP A 155 HIS A 160 SITE 4 BC3 25 PRO E 139 TRP E 155 HOH I2001 HOH I2002 SITE 5 BC3 25 HOH I2003 HOH I2004 HOH I2005 HOH I2006 SITE 6 BC3 25 HOH I2007 HOH I2008 MLE M 3 MLE M 10 SITE 7 BC3 25 ALA M 11 SITE 1 BC4 21 ARG B 89 PHE B 94 GLN B 97 GLY B 106 SITE 2 BC4 21 ALA B 135 ASN B 136 ALA B 137 GLN B 145 SITE 3 BC4 21 PHE B 147 TRP B 155 HIS B 160 HOH B2061 SITE 4 BC4 21 TRP D 155 HOH J2002 HOH J2003 HOH J2004 SITE 5 BC4 21 HOH J2007 HOH J2008 BMT L 5 MLE L 10 SITE 6 BC4 21 ALA L 11 SITE 1 BC5 21 ARG C 89 PHE C 94 GLN C 97 GLY C 106 SITE 2 BC5 21 ALA C 135 ASN C 136 ALA C 137 GLN C 145 SITE 3 BC5 21 PHE C 147 TRP C 155 HIS C 160 TRP F 155 SITE 4 BC5 21 HOH K2001 HOH K2002 HOH K2003 HOH K2004 SITE 5 BC5 21 HOH K2005 HOH K2006 MLE N 3 BMT N 5 SITE 6 BC5 21 MLE N 10 SITE 1 BC6 18 TRP B 155 ARG D 89 PHE D 94 GLN D 97 SITE 2 BC6 18 GLY D 106 ALA D 135 ASN D 136 GLN D 145 SITE 3 BC6 18 PHE D 147 TRP D 155 HIS D 160 MLE J 3 SITE 4 BC6 18 MLE J 10 HOH J2007 HOH L2001 HOH L2002 SITE 5 BC6 18 HOH L2003 HOH L2004 SITE 1 BC7 23 PRO A 139 TRP A 155 LYS A 159 ARG E 89 SITE 2 BC7 23 PHE E 94 GLN E 97 GLY E 106 ALA E 135 SITE 3 BC7 23 ASN E 136 GLN E 145 PHE E 147 TRP E 155 SITE 4 BC7 23 HIS E 160 MLE I 3 BMT I 5 MLE I 10 SITE 5 BC7 23 ALA I 11 HOH I2007 HOH M2001 HOH M2002 SITE 6 BC7 23 HOH M2003 HOH M2004 HOH M2005 SITE 1 BC8 22 ALA C 137 TRP C 155 ARG F 89 PHE F 94 SITE 2 BC8 22 GLN F 97 GLY F 106 THR F 107 ALA F 135 SITE 3 BC8 22 ASN F 136 GLN F 145 PHE F 147 TRP F 155 SITE 4 BC8 22 HIS F 160 BMT K 5 MLE K 10 ALA K 11 SITE 5 BC8 22 HOH K2005 HOH N2001 HOH N2003 HOH N2004 SITE 6 BC8 22 HOH N2005 HOH N2006 CRYST1 72.203 123.802 135.250 90.00 90.00 90.00 P 21 21 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013850 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008077 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007394 0.00000